NCT02054143View on ClinicalTrials.gov

The Effect of Sevoflurane on Cerebral CO2 Sensitivity and Systemic Arteries

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Sevoflurane Anesthesia
Interventions
PROCEDURE

Partial pressure of CO2 at the end of an exhaled breath

Three previously defined EtCO2 levels (partial pressure of CO2 at the end of an exhaled breath) were adjusted during anesthesia.

DRUG

Sevoflurane

Sevoflurane was administered to all patients at 1 minimal alveolar concentration (MAC) during the whole operation.

Trial Locations (1)

4032

University of Debrecen Medical and Health Science Center Department of Anesthesiology and Intensive Care, Debrecen

All Listed Sponsors
lead

University of Debrecen

OTHER

NCT02054143 - The Effect of Sevoflurane on Cerebral CO2 Sensitivity and Systemic Arteries | Biotech Hunter | Biotech Hunter